Evidence map›Paper›PMID 32167472›Full record

ArticleeLife2020

A loop structure allows TAPBPR to exert its dual function as MHC I chaperone and peptide editor.

Lina Sagert, Felix Hennig, Christoph Thomas, Robert Tampé

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CryoEM structure of an MHC-I/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lina SagertInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.
Felix HennigInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.
Christoph ThomasInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.ORCID 0000-0001-7441-1089
Robert TampéInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.ORCID 0000-0002-0403-2160
Goethe University Frankfurt · DE

Funding

Deutsche Forschungsgemeinschaft TA 157/12-1European Commission ERC_AdG 789121European Research Council ERC_AdG 789121
6 · The paper itself

Abstract

Adaptive immunity vitally depends on major histocompatibility complex class I (MHC I) molecules loaded with peptides. Selective loading of peptides onto MHC I, referred to as peptide editing, is catalyzed by tapasin and the tapasin-related TAPBPR. An important catalytic role has been ascribed to a structural feature in TAPBPR called the scoop loop, but the exact function of the scoop loop remains elusive. Here, using a reconstituted system of defined peptide-exchange components including human TAPBPR variants, we uncover a substantial contribution of the scoop loop to the stability of the MHC I-chaperone complex and to peptide editing. We reveal that the scoop loop of TAPBPR functions as an internal peptide surrogate in peptide-depleted environments stabilizing empty MHC I and impeding peptide rebinding. The scoop loop thereby acts as an additional selectivity filter in shaping the repertoire of presented peptide epitopes and the formation of a hierarchical immune response.

Indexed as

Gene Expression RegulationHistocompatibility Antigens Class IHumansImmunoglobulinsMembrane ProteinsModels, MolecularMolecular ChaperonesProtein ConformationHistocompatibility Antigens Class IImmunoglobulinsMembrane ProteinsMolecular ChaperonesTAPBPL protein, humanadaptive immunityantigen processingbiochemistrychaperoneschemical biologyhumanimmunologyinflammationMHCmhc class i moleculesmousepeptide editingquality contol

Identifiers

PMID32167472
PMCPMC7117912
OpenAlexW3011685884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.